OptiBiotix Health (LON:OPTI) Reaches New 1-Year Low – Time to Sell?

OptiBiotix Health Plc (LON:OPTI)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The company traded as low as GBX 7.50 and last traded at GBX 7.60, with a volume of 143170 shares traded. The stock had previously closed at GBX 7.75.

OptiBiotix Health Price Performance

The stock has a market capitalization of £7.75 million, a P/E ratio of -250.00 and a beta of 1.71. The stock’s fifty day moving average is GBX 8.72 and its 200-day moving average is GBX 10.74.

OptiBiotix Health (LON:OPTI) last posted its earnings results on Tuesday, September 16th. The company reported GBX (1.15) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.

Insider Buying and Selling

In related news, insider David Blain bought 84,053 shares of OptiBiotix Health stock in a transaction that occurred on Wednesday, October 1st. The stock was purchased at an average cost of GBX 1,175 per share, for a total transaction of £987,622.75. Also, insider Stephen O’Hara bought 95,238 shares of the firm’s stock in a transaction on Tuesday, September 23rd. The shares were bought at an average cost of GBX 11 per share, with a total value of £10,476.18. Insiders purchased a total of 229,291 shares of company stock worth $100,309,893 over the last three months. 26.82% of the stock is owned by company insiders.

About OptiBiotix Health

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.